← Leaderboards
Guojun Li
University Of Tx Md Anderson Can Ctr
$2,468,355
Attributed
$2,468,355
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $385K · FY2008–24$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,468,355 · 4
By mechanism
R01$1,469,677 · 1
K07$680,400 · 1
R03$318,278 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Heath Devin Skinner$8,539,031
- Katherine Arnold Hutcheson$5,107,957
- John V. Heymach$11,138,593
- Michael W Andreeff$17,991,896
- Erich M Sturgis$2,392,613
Others in their field
Top investigators on “Young Adult”
- Peter C Adamson · National Childhood Cancer Foundation$168,280,116
- Lloyd D Johnston · University Of Michigan At Ann Arbor$105,991,661
- Barbara Driver · Westat, Inc.$99,188,374
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$91,052,672
- James E. Gern · University Of Wisconsin-Madison$88,920,590
- Mitchell D Schnall · University Of Pennsylvania$82,329,292
Research focus
Young AdultOncogenicQuality Of LifeIncidenceTumorMolecularInfectionPathway InteractionsOropharyngeal Squamous Cell CarcinomaEtiologyUniversity Of Texas M D Anderson Cancer CenterTreatment ResponseEpidemiologyGenesExhibitsPrognosticSerumHuman PapillomavirusMalignant NeoplasmsPredispositionMalignant Oropharynx NeoplasmCancer PatientVaccinationResponse
Grant awards (14)
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients$252,901
R01 · FY2024 · CA · contact PI
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients$97,182
R01 · FY2023 · CA · contact PI
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients$363,602
R01 · FY2022 · CA · contact PI
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients$371,014
R01 · FY2021 · CA · contact PI
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients$384,978
R01 · FY2020 · CA · contact PI
Inflammatory Response miRNAs Predict HPV-associated Oropharyngeal Cancer Outcome$82,139
R03 · FY2016 · CA · contact PI
Inflammatory Response miRNAs Predict HPV-associated Oropharyngeal Cancer Outcome$82,139
R03 · FY2015 · CA · contact PI
Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients$136,080
K07 · FY2012 · CA · contact PI
Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients$136,080
K07 · FY2011 · CA · contact PI
Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients$136,080
K07 · FY2010 · CA · contact PI
Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients$136,080
K07 · FY2009 · CA · contact PI
Cytokine Variants as Predictors of HPV-16 Status & Outcome of Oropharyngeal Cance$77,000
R03 · FY2009 · CA · contact PI
Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients$136,080
K07 · FY2008 · CA · contact PI
Cytokine Variants as Predictors of HPV-16 Status & Outcome of Oropharyngeal Cance$77,000
R03 · FY2008 · CA · contact PI